TKT and neoplasm: Similar results were obtained in vivo: mammary adenocarcinomas (TSA-tk tumours) could be eliminated in almost all animals by systemic GCV administration (150 mg kg−1 GCV i.p. twice daily during 5 days), whereas T-cell lymphomas (ESB-tk tumours) were completely resistant to GCV treatment.